NovoCure Limited — Quarterly Financial Statistics (NASDAQ:NVCR) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 10.38 M-17.3 M35.66 M15.94 M20.57 M-23.14 M 49.03 M Cash from investing activities 10.19 M-490.61 M6.47 M35.99 M71.44 M323.38 M 437.28 M Cash from financing activities 100 K2.69 M5.25 M2.39 M100.52 M343.19 M 451.34 M Free cash flow -307 K-26.24 M25.05 M10.45 M14.92 M-28.04 M 22.38 M

Notizie

NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates

NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript

Gli EPS di Novocure Ltd hanno battuto le aspettative per 0,19$, il fatturato supera le previsioni

Novocure Ltd earnings beat by $0.19, revenue topped estimates

Netflix and Palantir among market cap stock movers on Wednesday

Novocure earnings up next: Pancreatic cancer launch in focus

Oracle and Netflix among market cap stock movers on Wednesday

Le azioni Novocure balzano dopo il ripristino della fatturazione Medicare

Novocure stock jumps after Medicare billing restored

Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching